Electrical Current Technique Offers Non-Surgical Alternative to LASIK Vision Correction
By
bilsbie
An everything bagel for the brain. Substantive, layered, well-seasoned.
Summary
Scientists have developed a non-surgical vision correction technique using electrical currents and custom contact lenses to reshape corneas. In rabbit tests, the method successfully corrected vision in just one minute without surgery, lasers, or cutting, potentially offering a safer alternative to LASIK procedures.
Key quotes
· 3 pulledUsing tiny electrical currents and custom contact lenses, researchers reshaped rabbit corneas in just a minute — a process that could one day replace LASIK.
Scientists may have found a way to correct vision without surgery, lasers, or cutting.
A new technique uses electricity to reshape the cornea, offering a surgery-free alternative to LASIK.
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
